Phase III randomized clinical trial

Grant Details

Grantee Name:
 Dr. Berit Mosgaard
Organization:
 Copenhagen University Hospital
Country: Denmark

Project Name:
 Phase III randomized clinical trial for stage III epithelial ovarian cancer -  OVHIPEC-2
Funding Year:
 2020
Project period: 4 years

Phase III randomized clinical trial for stage III epithelial ovarian cancer -  OVHIPEC-2

This clinical trial is a multi-center phase III study including 8 countries and 538 patients. This study is led by the Netherlands Cancer Institute and the funding requested is to cover the cost of pharmacovigilance.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.